Clinical Outcomes
hypo/mania, Depressive, bipolar I or II disorders, depressive symptoms
The sample characteristics are described in Table The FFT-HR and EC groups were matched in treatment duration (4 months) but not in the number of sessions (12 There was no evidence that the treatment delayed or prevented the onset of bipolar I or II disorders, which was observed in 18 of the 113 cases (15.9%) with at least one follow-up assessment. Depressive symptoms were far more common during follow-up than symptoms of hypo/mania, with about half (50.8%) of the sample experiencing a course characterized by persistent depressive symptoms, 16.5% experiencing an ongoing, moderately symptomatic course, and one-third (32.5%) experiencing a significantly improving course over time [